PofoliaShared via Pofolia

Molecular Oral Microbiology· 2026Q1

Hu Mei Qing Yan Ke Li Alleviates Periodontitis by Modulating the Oral Microbiome

Xia Wang, Heqiong Zheng, Yun‐Zhi Feng, Fengyi Zhang

Short summary

Hu Mei Qing Yan Ke Li (HM) treatment significantly improved bone structure in a mouse model of periodontitis, increasing bone volume/tissue volume (BV/TV) from 41.89% to 54.41% and altering the oral microbiome.

AI-generated from the title and abstract; the full text is not read.

Key points

  • HM treatment significantly increased bone volume/tissue volume (BV/TV) from 41.89% to 54.41% (p = 0.0019) in periodontitis-affected mice.
  • HM treatment upregulated OPG and downregulated RANKL expression in periodontal tissues.
  • HM restructured the subgingival microbial community, suppressing pathobionts and enriching beneficial bacteria.
  • Key suppressed bacteria included Streptococcus acidominimus (16.95% to 9.37%) and Rodentibacter pneumotropicus (70.32% to 16.46%).
  • Key enriched bacteria included Streptococcus danieliae (0.75% to 30.68%) and unclassified Ligilactobacillus (1.57% to 22.74%).

AI-generated from the title and abstract; the full text is not read.

Abstract

BACKGROUND: Periodontitis is a prevalent chronic inflammatory disease driven by dysbiosis of the oral microbiota. Hu Mei Qing Yan Ke Li (HM), a modern herbal formulation derived from Reynoutria japonica Houtt and Prunus mume Siebold & Zucc, exhibits anti-inflammatory, antioxidant, and antibacterial properties, suggesting promising therapeutic potential for periodontitis therapy. This study aimed to investigate the protective effects of HM against experimental periodontitis and further explore its underlying mechanisms. METHODS: Periodontitis was induced by ligature placement in C57BL/6 mice. Mice were randomly assigned to the untreated periodontitis (P) and HM-treated (P + HM) groups. Mice in the P + HM group received HM via daily oral gavage at 6.58 mg/g body weight for 2 weeks. Alveolar bone loss was assessed by micro-CT analysis. Periodontal tissue destruction and osteoclast activity were evaluated by H&E, Masson's, and TRAP staining. Expression of OPG and RANKL was detected by immunofluorescence. Subgingival microbiota composition was analyzed by 16S rRNA sequencing. RESULTS: HM treatment significantly inhibited osteoclastogenesis and alleviated alveolar bone resorption, while preserving periodontal tissue integrity. Quantitatively, HM treatment significantly increased BV/TV from 41.89% to 54.41% (p = 0.0019), Tb.Th from 111.5 to 131.2 µm (p = 0.0028), and Tb.Sp from 119.2 to 153.6 µm (p = 0.0015), while decreasing BS/BV from 0.03166 to 0.02655 1/µm (p = 0.0004). Mechanistically, HM upregulated OPG and downregulated RANKL expression in periodontal tissues. Notably, HM restructured the subgingival microbial community, suppressing the pathobiont Streptococcus acidominimus (16.95%-9.37%, p = 0.0411) and Rodentibacter_A_734545pneumotropicus (70.32%-16.46%, p < 0.0001), while enriching a beneficial consortium including Streptococcus danieliae (0.75%-30.68%, p < 0.0001), unclassified Corynebacterium (0.00%-6.50%, p = 0.0022), and unclassified Ligilactobacillus (1.57%-22.74%, p = 0.0063). CONCLUSION: HM alleviates periodontitis by remodeling the dysbiotic oral microbiome toward homeostasis and favorably modulating the OPG/RANKL axis in a murine ligature-induced periodontitis model.

The authors' abstract, as published at the source. Molecular Oral Microbiology, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Periodontics

PeriodonticsDentistry